➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Mallinckrodt
McKinsey
Johnson and Johnson
Baxter

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Bupivacaine Hydrochloride Preservative Free patents expire, and when can generic versions of Bupivacaine Hydrochloride Preservative Free launch?

Bupivacaine Hydrochloride Preservative Free is a drug marketed by Aurobindo Pharma Ltd, Intl Medicated, and Mylan Asi. and is included in three NDAs.

The generic ingredient in BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Bupivacaine Hydrochloride Preservative Free

A generic version of BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE was approved as bupivacaine hydrochloride by HOSPIRA on December 11th, 1987.

  Start Trial

Summary for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Drug patent expirations by year for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Recent Clinical Trials for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityPhase 4
Hospital for Special Surgery, New YorkPhase 4
Mansoura UniversityPhase 4

See all BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE clinical trials

Pharmacology for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895-001 Nov 5, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Asi BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 091487-002 Oct 18, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Intl Medicated BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 076012-001 Jan 9, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Asi BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 091487-001 Oct 18, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Mallinckrodt
McKinsey
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.